Fellow, National Academy of Sciences, Allahabad

Fellow, Academy of Sciences, Thiruvananthapuram, India

Ruby John Anto, A chemotherapeutic composition used in the treatment of cancer: Filing Number: #1184/Del/2004. IPR- Patent number: 241416, Date of grant-02/07/2010: Funding by DBT, Govt. of India

Ruby John Anto and Lakshmi R Nath, Uttroside B and derivatives thereof as therapeutics for hepatocellular carcinoma, funding by Rajiv Gandhi Centre For Biotechnology.
National Patent Application No. 201641018401 dated 28^th May 2016
International patent Application No. PCT/ IN20 17/050204 dated 27^th May 2017
Current patent Status
India- Replied to FER on Dec 14,2020 (Application in Amended Examination)

1. US: WIPO patentscope number US20190160088, November 26,2018, Patent granted.
2. Canada: WIPO patentscope number 3,026,426, November 28,2018, Patent granted.
3. Japan: WIPO patentscope number JP2019520425, Patent granted.
4. South Korea: WIPO patentscope number KR1020190008323, Patent granted.

Signed an MOU with Oklahoma Medical Research Foundation, USA for the clinical translation of Uttroside B in liver cancer patients on January 31, 2017.

Transferred the technology to the multi-national company, Q Biomed. And received the first milestone payment on June 15, 2017.
(https://adisinsight.springer.com/drugs/800048876);
https://qbiomed.com/index.php/pipeline/uttroside

Received Orphan Drug Designation to Uttroside B on January 27, 2021.
https://www.prnewswire.com/news-releases/q-biomeds-uttroside-b-receives-us-fda-orphan-drug-designation-in-the-treatment-of-liver-cancer-301215876.html
https://www.biospace.com/article/releases/q-biomed-s-uttroside-b-receives-u-s-fda-orphan-drug-designation-in-the-treatment-of-liver-cancer/

Ruby John Anto and Jayesh Antony, Extracts from a plant, processes for obtaining the extracts and fractions and applications thereof, Filed on: 20.09.2010, Patent Application No. 2743/CHE/2010: Funding by RGCB

C Mohandas, Bala Nambisan, Ruby John Anto, Vino T. Cheriyan and S. Nishanth Kumar. Anticancer activity of a cyclic dipeptide isolated from novel bacteria associated with Rhabditis sp., Filed on: 11-03-2011 Patent Application No. 820/CHE/2011). Funding by Indian Council for Agricultural Research

Member, European Association For Cancer Research

Member, American Association of Cancer Research

Member, Editorial board - PLOS ONE

Member, Editorial Board, Science Letters

Member, Editorial board- Asian Journal of Pharmacological Sciences

Member, American Society For Biochemistry And Molecular Biology

Member, The Biotech Research Society

Member, Board of Studies, M.Sc Chemistry, University of Kerala (2004-2007)

Member, Board of Studies, MSc Biotechnology, University of Calicut (2007-2010)

Funding Agencies

• Department of Science and Technology
• Council of Scientific and Industrial Research
• Indian Council of Medical Research

Journals

• Antioxid Redox Sign
• Apoptosis
• Plos One
• Int. J. Cancer
• J. Cellular and Mol. Med.
• Cell Death &Dis
• BMC Cancer
• Immunopharmacol and Immunotoxicol
• Drug Delivery
• Evidence Based Complementary &Alternative Med
• Free Rad Res
• J.Stem Cells
• Therapeutic Delivery
• Int J Pharm
• Intl J Biochem & Cell Biol